**Core Concept**
In acute severe asthma, the primary goal is to alleviate bronchospasm, reduce airway inflammation, and restore normal respiratory function. This can be achieved through the administration of bronchodilators, corticosteroids, and other medications that target the underlying pathophysiology of asthma.

**Why the Correct Answer is Right**
The management of acute severe asthma involves the use of inhaled beta-2 agonists, such as albuterol, to rapidly relax bronchial smooth muscles and improve airflow. Corticosteroids, like dexamethasone, are also administered to reduce airway inflammation and prevent further exacerbations. Magnesium sulfate may be used as an adjunct therapy to enhance the effects of bronchodilators and reduce airway resistance. In severe cases, intravenous aminophylline or epinephrine may be considered to provide rapid bronchodilation and improve respiratory status.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because, although theophylline has some bronchodilatory effects, it is not typically used as a first-line treatment for acute severe asthma due to its narrow therapeutic index and potential for side effects.
**Option B:** This option is incorrect because ipratropium bromide, an anticholinergic agent, can be used in conjunction with beta-2 agonists to provide additional bronchodilation, but it is not a primary treatment for acute severe asthma.
**Option C:** This option is incorrect because montelukast, a leukotriene receptor antagonist, is used for long-term control of asthma symptoms, but it is not indicated for acute severe asthma exacerbations.

**Clinical Pearl / High-Yield Fact**
In acute severe asthma, the "3 Rs" of management are to Reverse bronchospasm, Reduce airway inflammation, and Restore normal respiratory function. This can be remembered using the mnemonic "RRR" - Relax (bronchospasm), Reduce (inflammation), Restore (respiratory function).

**Correct Answer:** C. Magnesium sulfate.